Physician profile
Christopher D Morris
NPI 1104026939
$21,126.69
in general payments reported to CMS, 2019-2025
9 companies · $3,015 in 2025
The $3,015 reported for 2025 was more than what 94% of Oral and Maxillofacial Surgery providers received nationally (typical 2025 total: $150).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $206 · 2020: $70.00 · 2021: $17K · 2022: $339 · 2023: $729 · 2024: $244 · 2025: $3,015.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Honoraria: $3,000 · Gift: $769 · Food and Beverage: $219.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Honoraria | $3,000.00 |
| Gift | $769.18 |
| Food and Beverage | $219.39 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Straumann USA LLC | $19,931.70 | 2021-2025 | |
| Purelife, LLC | $730.00 | 2020-2023 | |
| Ultradent Products INC | $207.20 | 2024 | Opalescence |
| Biohorizons Implant Systems INC. | $67.60 | 2019-2025 | Biohorizons Dental Implants |
| Biolase, INC. | $48.04 | 2019 | |
| Keystone Dental INC. | $37.84 | 2019 | |
| Pacira Pharmaceuticals Incorporated | $36.21 | 2021-2024 | Exparel |
| Depuy Synthes Sales INC. | $35.60 | 2019 | |
| Nobel Biocare USA | $32.50 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Christopher Morris listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.